Stem Cell Transplant

What a stem cell transplant actually is

Stem cells are the original cells in your bone marrow from which every blood cell — red, white, platelet — is descended. A stem cell transplant replaces a damaged or diseased marrow with healthy stem cells, either your own (collected and stored earlier) or a donor's. Once infused into your bloodstream, the stem cells find their way back to the marrow cavity and, over two to three weeks, begin producing new blood cells.

The transplant itself is a brief, almost anticlimactic moment — a bag of cells running in through a drip, like a transfusion. The work is everything around it: the high-dose chemotherapy that comes before, and the recovery that comes after.

Autologous vs allogeneic — the basic difference

When transplant is considered

Transplant is not a treatment we recommend lightly. It is offered when the disease in question is unlikely to be cured by conventional treatment alone, and when the potential benefits outweigh the substantial risks. The commonest situations include:

• High-risk acute leukemias (AML, ALL) — particularly when adverse genetics are present, or after relapse.
• Relapsed or refractory lymphoma — autologous transplant for chemosensitive relapse; allogeneic for certain T-cell and refractory cases.
• Multiple myeloma — autologous transplant, in eligible patients, as part of first-line treatment.
• Severe aplastic anaemia — allogeneic transplant, especially in younger patients with a matched sibling.
• Myelofibrosis — allogeneic transplant for intermediate-2 and high-risk patients.
• High-risk myelodysplastic syndromes — allogeneic transplant for fitter patients.
• Selected inherited disorders — thalassaemia major and sickle cell disease in children with matched donors.

"Sending a patient for transplant is one of the biggest decisions we make together. We don't take it lightly — but when the maths is right, transplant offers cure where nothing else can. And we don't disappear when you go. We stay in the loop, before, during, and after."

How we work with transplant centres

Pakistan now has a small but growing network of accredited transplant centres. Dr. Rehan refers to and coordinates with established programs — both within Pakistan and, when patients prefer or require, abroad. Our role through the process includes:

• Identifying transplant candidacy early — so the timing isn't wasted.
• Getting the disease into the right state — for most diseases, transplant works best when disease burden is at its lowest. We use induction and bridging treatment to get there.
• Pre-transplant workup — HLA typing for you and family members, organ function tests, infection screening, dental review.
• Choosing the centre together — based on the disease, your insurance and finances, family support, and your preferences.
• Shared care during transplant — staying in contact with the transplant team and with you.
• Long-term follow-up — most transplant survivors are followed back in our clinic for years, with periodic transplant-centre input for specific issues.

The basic timeline — autologous transplant

1. Eligibility and workup (2-4 weeks) — confirming candidacy, organ function tests, HLA typing where relevant.
2. Stem cell mobilisation and collection (1-2 weeks) — a growth-factor injection (G-CSF), sometimes with chemotherapy, is given to push stem cells into the bloodstream. The cells are then collected through a leukapheresis machine over a few hours and frozen.
3. Conditioning chemotherapy (a few days) — high-dose chemotherapy (such as melphalan in myeloma) given in hospital, designed to clear the marrow.
4. Stem cell infusion (Day 0) — your frozen stem cells are thawed and infused through a drip.
5. Engraftment phase (Day 0 to about Day 14) — counts fall to very low levels; supportive care with transfusions, antibiotics, antifungals, and careful nutrition. Most patients spend two to three weeks in hospital. Engraftment — when new blood cells start appearing — typically occurs around Day 10-14.
6. Discharge and recovery (Day 14-30) — once counts have recovered and you're eating, drinking and well, you go home. Frequent outpatient visits for the next several weeks.
7. Return to normal life — gradually, over three to six months.

The basic timeline — allogeneic transplant

1. Donor identification — HLA typing of you, then siblings, then (if needed) the unrelated donor registry, then possibly haploidentical family donors. This can take weeks to months.
2. Pre-transplant workup — comprehensive organ function testing, infection screening, dental review, fertility discussion if relevant, psychological preparation.
3. Conditioning regimen (about a week) — chemotherapy with or without total body irradiation, designed both to clear the marrow and to suppress your immune system enough to accept the donor cells.
4. Donor cell infusion (Day 0).
5. Engraftment phase (Day 0 to about Day 30) — the most demanding period. Counts are very low; infection risk is high; mucositis (mouth and gut inflammation) is common; you live in a protected hospital environment with strict infection precautions.
6. Early post-transplant (Day 30 to Day 100) — engraftment is established; we watch closely for graft-versus-host disease and for opportunistic infections. Immunosuppressant medicines are taken daily.
7. Late recovery (Day 100 to one year and beyond) — immune system slowly reconstitutes; vaccinations are restarted; immunosuppression is tapered as tolerated. Most allogeneic survivors are off immunosuppression by one to two years and living more or less normally — but follow-up continues lifelong.

What recovery is really like — honestly

Stem cell transplant is one of the most demanding treatments in modern medicine. Patients describe the hospital stay as the hardest few weeks of their lives — extreme fatigue, mouth and gut soreness, infections, dependence on others for the most basic things. Coming home is a relief, but recovery continues for months — strength returns slowly, infections are easier to catch, and there is psychological work in adjusting to what's been gone through.

By six months to a year, most patients are back to a recognisably normal life. By two years, many have returned to work, travel, and most activities. We will be honest with you upfront: the recovery is a marathon, not a sprint. Family support — practical and emotional — is genuinely essential.

Risks — what to know

Different transplants carry different risks, and your transplant team will discuss your specific numbers with you. Broadly:

• Infections — particularly during neutropenia and (in allogeneic transplants) during the first months as immunity reconstitutes.
• Graft-versus-host disease (GVHD) — only in allogeneic transplants — the donor's immune cells reacting against your tissues. Can be acute (early) or chronic (months later); skin, gut and liver most commonly affected. Manageable in most cases; serious in a minority.
• Organ toxicity from the conditioning regimen — heart, lungs, liver, kidneys.
• Fertility — most transplant regimens cause infertility; fertility preservation must be discussed before treatment when relevant.
• Late effects — secondary cancers, hormonal changes, bone health, lung issues — watched for in long-term follow-up.
• Transplant-related mortality — exists, varies by patient and disease, and is part of the honest discussion before consent.

Life after transplant

Most long-term transplant survivors live full lives — work, travel, families, sometimes children (where fertility was preserved). The main ongoing themes:

• Regular monitoring in our clinic, with periodic transplant-centre visits.
• Re-vaccination over the first two years — childhood vaccinations need to be repeated.
• Sun protection — skin cancer risk is higher after transplant.
• Attention to bone, heart, lung, and hormonal health.
• Watchfulness for late GVHD and secondary cancers.
• Mental health support as needed — what you've been through is significant, and processing it takes time.

Common questions

"How do I find out if I have a matched donor?" HLA typing of you and your siblings is the first step — a simple blood test. If no sibling match is found, the search extends to unrelated registries and to haploidentical (half-matched) family options. Most patients today can find a usable donor through one of these routes.

"Can transplant be done in Pakistan?" Yes — both autologous and allogeneic transplants are performed in several established centres in Pakistan. For more complex cases, transplant abroad may be considered. We help you weigh the choice.

"Will Dr. Rehan still be my doctor after transplant?" Yes. Most patients return to our clinic for long-term follow-up, with the transplant centre's input for transplant-specific issues. We stay involved before, during, and after.

"How do I prepare?" Get as fit as you can be — walk, eat well, look after your teeth (a dental review is required), stop smoking, ensure vaccinations are up to date. Sort out the practical things at home and at work. Talk to your family about what's coming.

What to bring to a transplant-planning visit

• All disease-related reports — bone marrow, cytogenetics, molecular, imaging.
• Full treatment history to date.
• HLA typing results if already done.
• List of siblings and their availability for typing.
• Records of any significant illnesses (heart, lung, liver, kidney, infections like hepatitis or TB).
• A close family member who can help with planning and decisions.